The Influence Of Financial Development On The Agglomeration Of Biomedicine Industry In Our Country

The impact of the epidemic,the slowdown of domestic economic growth and the aging population with fewer children have put forward new requirements for China’s biomedical industry.The "Fourteenth Five-Year Plan" and the outline of the 2035 vision clearly put forward the planning goals and paths to promote the integration of biomedical industry,clustering,ecological development,and cultivate new momentum for economic development.At present,although China’s biopharmaceutical industry has initially presented a certain scale and a relatively complete industrial chain,the unbalanced development of its clusters and the homogeneity of industrial parks are prominent,and the dominant financing mode of the financial market does not match the financial needs of biopharmaceutical industry clusters,and the insufficient support of venture capital and capital market restrict the financial development to promote the technological innovation and cluster development of China’s biopharmaceutical industry.Therefore,this paper studies the influence role of financial development on the agglomeration of biopharmaceutical industry in China,which is of great practical significance to make a good investment and financing layout of biopharmaceutical industry and promote the high-level agglomeration development of biopharmaceutical industry.This paper collects and organizes data on financial development,technological innovation,and biomedical industry agglomeration in 31 provinces,cities and autonomous regions from 2003 to 2019,constructs a spatial econometric model based on financial development theory and industrial agglomeration theory,etc.,and analyzes the influence of financial development on the agglomeration of biomedical industry in China from three development levels: financial scale,financial efficiency,and financial structure.Its main content is divided into five parts: the first part is the introduction,this part contains the research background and significance,literature review and research content.The second part is the analysis of relevant theories and mechanisms,including the definition of the concepts related to financial development,biopharmaceuticals and industrial agglomeration,the elaboration of the theories related to financial development and industrial agglomeration,further analysis of the mechanism of financial development affecting industrial agglomeration and the research hypothesis.The third part is the analysis of the current situation of financial development and biomedical industry agglomeration in China.Firstly,it introduces the current situation of financial development,followed by the current situation of market scale development and industrial agglomeration development of biopharmaceutical industry in China.The fourth part is the empirical analysis of the impact of financial development on the agglomeration of biopharmaceutical industry in China.The fifth part is the research conclusion and countermeasure suggestions.Based on the above theoretical analysis,current situation analysis and empirical analysis summarize the research conclusions of this paper and put forward countermeasure suggestions.Research conclusions: First,the level of pharmaceutical industry aggregation among provinces in China is relatively different and uneven,but the spatial spillover effect is obvious.Second,the positive spatial spillover effect of financial efficiency level and financial structure level on the agglomeration of biomedical industry is obvious,and the direct effect,indirect effect and total effect are positive.Thirdly,the level of human capital,population structure and technological innovation level have significant effects on pharmaceutical industry agglomeration,and the spatial spillover effect is obvious.To this end,this paper proposes countermeasures: first,at the government level,strengthen the toplevel design and establish a regional cooperation system.Second,at the financial level,improve the financial system and provide accurate financial services.Finally,at the enterprise level,strengthen the position of innovation main body and promote the transformation of research results.